BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to the 340B Drug Pricing Program - regarding all bio-pharmaceutical related provisions H.R.7635, the 340B PATIENTS Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL CALVO | — |
| RODGER CURRIE | — |
| JOHN DEOUDES | — |
| SOFIA FOX | — |
| KIRBY MILLER | — |
| KATHRYN NOVARIA | — |
| LANE PENRY | — |
| STEVEN TILTON | — |
Health Issues HCR
H.R.1492, Ensuring Pathways to Innovation Cures (EPIC) Act Implementation of Inflation Reduction Act of 2022 ORPHAN Cures Act MINI Act H.R.4299, the Protecting Patient Access to Cancer and Complex Therapies Act of 2025 H.R.5509, Safe Step Act Issues related to biosimilars reimbursement issues Clinical Trial Modernization Act Essential medicines/Buy American regarding all bio-pharmaceutical provisions Discussions regarding condification of MFN policies Fixed dose conbination drugs and general research and development Prescription Information Modernization Act of 2026 (PIMA)
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BRUNET | — |
| MICHAEL CALVO | — |
| RODGER CURRIE | — |
| JOHN DEOUDES | — |
| SOFIA FOX | — |
| NICOLE L'ESPERANCE | — |
| KIRBY MILLER | — |
| KATHRYN NOVARIA | — |
| LANE PENRY | — |
| STEVEN TILTON | — |
Taxation/Internal Revenue Code TAX
Proposed policies regarding corporate tax reform - regarding all bio-pharmaceutical related provisions Discussions regarding OECD implementation
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BRUNET | — |
| MICHAEL CALVO | — |
| RODGER CURRIE | — |
| JOHN DEOUDES | — |
| LANE PENRY | — |
| STEVEN TILTON | — |
Copyright/Patent/Trademark CPT
Intellectual Property Reform concerning bio-pharmaceutical industry
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BRUNET | — |
| MICHAEL CALVO | — |
| RODGER CURRIE | — |
| SOFIA FOX | — |
| NICOLE L'ESPERANCE | — |
| LANE PENRY | — |
| STEVEN TILTON | — |
Trade (domestic/foreign) TRD
International Reference Pricing/Most Favored Nation, including all bio-pharmaceutical issues Issues concerning competitive trade
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BRUNET | — |
| MICHAEL CALVO | — |
| RODGER CURRIE | — |
| JOHN DEOUDES | — |
| SOFIA FOX | — |
| KIRBY MILLER | — |
| KATHRYN NOVARIA | — |
| LANE PENRY | — |
| STEVEN TILTON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.